Home › Research › Topics › restriction
restriction
2 studies tagged restriction, dated 2013-07-13 to 2023-03-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development 2023-03-01
- Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease 2013-07-13
Studies
2 studies carry this tag.
Date range
2013 to 2023
Top journals
- Brain research 1
- Lancet regional health. Americas 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
In 2021, the US Food and Drug Administration (FDA) granted approval to aducanumab, an antiamyloid antibody for early-stage Alzheimer's disease, despite a lack of clear clinical evidence demonstrating the drug's cognitive benefits.
-
Age-associated dysregulation of sleep can be worsened by Alzheimer's disease (AD).